{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:21:07Z","timestamp":1779236467956,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We evaluated the clinical outcomes of selective retina therapy (SRT) in patients with central serous chorioretinopathy (CSC) who had nonconforming focal choroidal excavations (FCEs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Among the 204 patients with chronic CSC who underwent SRT between June 2023 and February 2025, six patients (2.9%) with nonconforming FCEs were analyzed. Using a Q-switched Nd: YLF 527-nm laser device, SRT was applied at leaking points or in leakage areas according to the features observed on fundus fluorescein angiography. The mean best-corrected visual acuity (BCVA), central foveal thickness (CFT), subfoveal choroidal thickness height, and mean deviation (MD) of retinal sensitivity were measured during the follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the six patients, five patients showed complete subretinal fluid (SRF) resolution, while one patient demonstrated minimal persistent SRF during the follow-up period. Four patients showed an improvement in BCVA, while BCVA remained unchanged in the other two patients. All patients showed improvement in the MD of retinal sensitivity during the follow-up period. Among the six patients, two patients showed complete SRF resolution after a single session of SRT, while the other four patients required multiple SRT sessions. No SRT-related adverse events were observed during the follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SRT produced favorable outcomes in the treatment of patients with CSC and nonconforming FCEs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-025-00741-x","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:24:43Z","timestamp":1763738683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Selective retina therapy for central serous chorioretinopathy with focal choroidal excavation: a retrospective case series of six eyes"],"prefix":"10.1186","volume":"11","author":[{"given":"Seung Hee","family":"Jeon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Jung","family":"Roh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"2","key":"741_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","volume":"86","author":"M Wang","year":"2008","unstructured":"Wang M, Munch IC, Hasler PW, Pr\u00fcnte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol. 2008;86(2):126\u201345.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"741_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","volume":"115","author":"AS Kitzmann","year":"2008","unstructured":"Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP. The incidence of central serous chorioretinopathy in olmsted County, Minnesota, 1980\u20132002. Ophthalmology. 2008;115(1):169\u201373.","journal-title":"Ophthalmology"},{"issue":"1","key":"741_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/IAE.0000000000000837","volume":"36","author":"B Liu","year":"2016","unstructured":"Liu B, Deng T, Zhang J, RISK FACTORS FOR CENTRAL. SEROUS CHORIORETINOPATHY: A systematic review and Meta-Analysis. Retina. 2016;36(1):9\u201319.","journal-title":"Retina"},{"issue":"10","key":"741_CR4","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1167\/iovs.19-26781","volume":"60","author":"RL Schellevis","year":"2019","unstructured":"Schellevis RL, Altay L, Kalisingh A, Mulders TWF, Sitnilska V, Hoyng CB, et al. Elevated steroid hormone levels in active chronic central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2019;60(10):3407\u201313.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"741_CR5","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1097\/01.iae.0000248819.86737.a5","volume":"26","author":"LM Jampol","year":"2006","unstructured":"Jampol LM, Shankle J, Schroeder R, Tornambe P, Spaide RF, Hee MR. Diagnostic and therapeutic challenges. Retina. 2006;26(9):1072\u20136.","journal-title":"Retina"},{"issue":"1","key":"741_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000337880","volume":"3","author":"T Katome","year":"2012","unstructured":"Katome T, Mitamura Y, Hotta F, Niki M, Naito T. Two cases of focal choroidal excavation detected by spectral-domain optical coherence tomography. Case Rep Ophthalmol. 2012;3(1):96\u2013103.","journal-title":"Case Rep Ophthalmol"},{"issue":"10","key":"741_CR7","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1001\/archophthalmol.2011.148","volume":"129","author":"R Margolis","year":"2011","unstructured":"Margolis R, Mukkamala SK, Jampol LM, Spaide RF, Ober MD, Sorenson JA, et al. The expanded spectrum of focal choroidal excavation. Arch Ophthalmol. 2011;129(10):1320\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"741_CR8","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/IAE.0000000000000045","volume":"34","author":"M Suzuki","year":"2014","unstructured":"Suzuki M, Gomi F, Hara C, Sawa M, Nishida K. Characteristics of central serous chorioretinopathy complicated by focal choroidal excavation. Retina. 2014;34(6):1216\u201322.","journal-title":"Retina"},{"issue":"4","key":"741_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/archopht.1974.03900060257001","volume":"91","author":"ML Klein","year":"1974","unstructured":"Klein ML, Van Buskirk EM, Friedman E, Gragoudas E, Chandra S. Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol. 1974;91(4):247\u201350.","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"741_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/bjo.68.11.815","volume":"68","author":"CM Gilbert","year":"1984","unstructured":"Gilbert CM, Owens SL, Smith PD, Fine SL. Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol. 1984;68(11):815\u201320.","journal-title":"Br J Ophthalmol"},{"key":"741_CR11","doi-asserted-by":"publisher","first-page":"101236","DOI":"10.1016\/j.preteyeres.2024.101236","volume":"101","author":"HMA Feenstra","year":"2024","unstructured":"Feenstra HMA, van Dijk EHC, Cheung CMG, Ohno-Matsui K, Lai TYY, Koizumi H, et al. Central serous chorioretinopathy: an evidence-based treatment guideline. Prog Retin Eye Res. 2024;101:101236.","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"741_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/bjo.72.11.829","volume":"72","author":"L Ficker","year":"1988","unstructured":"Ficker L, Vafidis G, While A, Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol. 1988;72(11):829\u201334.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"741_CR13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3928\/1542-8877-19970801-16","volume":"28","author":"PK Khosla","year":"1997","unstructured":"Khosla PK, Rana SS, Tewari HK, Azad RU, Talwar D. Evaluation of visual function following argon laser photocoagulation in central serous retinopathy. Ophthalmic Surg Lasers. 1997;28(8):693\u20137.","journal-title":"Ophthalmic Surg Lasers"},{"issue":"3","key":"741_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1755-3768.2008.01408.x","volume":"88","author":"JM Ruiz-Moreno","year":"2010","unstructured":"Ruiz-Moreno JM, Lugo FL, Armad\u00e1 F, Silva R, Montero JA, Arevalo JF, et al. Photodynamic therapy for chronic central serous chorioretinopathy. Acta Ophthalmol. 2010;88(3):371\u20136.","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"741_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ajo.2009.08.026","volume":"149","author":"M Reibaldi","year":"2010","unstructured":"Reibaldi M, Cardascia N, Longo A, Furino C, Avitabile T, Faro S, et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol. 2010;149(2):307\u2013. \u2013\u200915.e2.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"741_CR16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ophtha.2013.11.040","volume":"121","author":"JI Lim","year":"2014","unstructured":"Lim JI, Glassman AR, Aiello LP, Chakravarthy U, Flaxel CJ, Spaide RF. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology. 2014;121(5):1073\u20138.","journal-title":"Ophthalmology"},{"key":"741_CR17","first-page":"51","volume":"302","author":"R Brinkmann","year":"2006","unstructured":"Brinkmann R, Roider J, Birngruber R. Selective retina therapy (SRT): a review on methods, techniques, preclinical and first clinical results. Bull Soc Belge Ophtalmol. 2006;302:51\u201369.","journal-title":"Bull Soc Belge Ophtalmol"},{"issue":"1","key":"741_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00417-020-04887-2","volume":"259","author":"SH Jeon","year":"2021","unstructured":"Jeon SH, Kim M, Roh YJ. Retinal pigment epithelial responses based on the irradiation density of selective retina therapy. Graefes Arch Clin Exp Ophthalmol. 2021;259(1):101\u201311.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"741_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/bjo.2009.178327","volume":"95","author":"C Klatt","year":"2011","unstructured":"Klatt C, Saeger M, Oppermann T, P\u00f6rksen E, Treumer F, Hillenkamp J, et al. Selective retina therapy for acute central serous chorioretinopathy. Br J Ophthalmol. 2011;95(1):83\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"741_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00417-016-3441-8","volume":"255","author":"A Yasui","year":"2017","unstructured":"Yasui A, Yamamoto M, Hirayama K, Shiraki K, Theisen-Kunde D, Brinkmann R, et al. Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2017;255(2):243\u201354.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"741_CR21","doi-asserted-by":"publisher","first-page":"17557","DOI":"10.1038\/s41598-022-22513-5","volume":"12","author":"SW Nam","year":"2022","unstructured":"Nam SW, Lee JH, Byun Z, Ham DI, Kong M. Evaluation of the microperimetry in eyes with cuticular Drusen. Sci Rep. 2022;12(1):17557.","journal-title":"Sci Rep"},{"key":"741_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jcm13175230","volume":"13","author":"SH Jeon","year":"2024","unstructured":"Jeon SH, Kim M, Roh YJ. Use of a fundus Image-Based Titration strategy for selective retina therapy for central serous chorioretinopathy. J Clin Med. 2024;13:17.","journal-title":"J Clin Med"},{"issue":"4","key":"741_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.ajo.2013.05.010","volume":"156","author":"AA Ellabban","year":"2013","unstructured":"Ellabban AA, Tsujikawa A, Ooto S, Yamashiro K, Oishi A, Nakata I, et al. Focal choroidal excavation in eyes with central serous chorioretinopathy. Am J Ophthalmol. 2013;156(4):673\u201383.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"741_CR24","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1111\/j.1755-3768.2010.01895.x","volume":"88","author":"Y Wakabayashi","year":"2010","unstructured":"Wakabayashi Y, Nishimura A, Higashide T, Ijiri S, Sugiyama K. Unilateral choroidal excavation in the macula detected by spectral-domain optical coherence tomography. Acta Ophthalmol. 2010;88(3):e87\u201391.","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"741_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/IAE.0000000000001345","volume":"37","author":"H Chung","year":"2017","unstructured":"Chung H, Byeon SH, Freund KB, FOCAL CHOROIDAL EXCAVATION AND ITS ASSOCIATION WITH PACHYCHOROID. SPECTRUM DISORDERS: A review of the literature and multimodal imaging findings. Retina. 2017;37(2):199\u2013221.","journal-title":"Retina"},{"key":"741_CR26","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.2147\/OPTH.S33879","volume":"6","author":"W Kobayashi","year":"2012","unstructured":"Kobayashi W, Abe T, Tamai H, Nakazawa T. Choroidal excavation with polypoidal choroidal vasculopathy: a case report. Clin Ophthalmol. 2012;6:1373\u20136.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"741_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ophtha.2013.08.014","volume":"121","author":"H Xu","year":"2014","unstructured":"Xu H, Zeng F, Shi D, Sun X, Chen X, Bai Y. Focal choroidal excavation complicated by choroidal neovascularization. Ophthalmology. 2014;121(1):246\u201350.","journal-title":"Ophthalmology"},{"issue":"1","key":"741_CR28","doi-asserted-by":"publisher","first-page":"12187","DOI":"10.1038\/s41598-025-95561-2","volume":"15","author":"P Liu","year":"2025","unstructured":"Liu P, An G, Lu C, Li S, Chen H, Jin B, et al. Analysis of clinical features and SS-OCT findings in patients with focal choroidal excavation. Sci Rep. 2025;15(1):12187.","journal-title":"Sci Rep"},{"issue":"4","key":"741_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/eye.2015.31","volume":"29","author":"FO Luk","year":"2015","unstructured":"Luk FO, Fok AC, Lee A, Liu AT, Lai TY. Focal choroidal excavation in patients with central serous chorioretinopathy. Eye (Lond). 2015;29(4):453\u20139.","journal-title":"Eye (Lond)"},{"issue":"10","key":"741_CR30","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","volume":"29","author":"Y Imamura","year":"2009","unstructured":"Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29(10):1469\u201373.","journal-title":"Retina"},{"issue":"9","key":"741_CR31","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","volume":"117","author":"I Maruko","year":"2010","unstructured":"Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology. 2010;117(9):1792\u20139.","journal-title":"Ophthalmology"},{"issue":"7","key":"741_CR32","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00417-017-3672-3","volume":"255","author":"YG Park","year":"2017","unstructured":"Park YG, Kang S, Kim M, Yoo N, Roh YJ. Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients. Graefes Arch Clin Exp Ophthalmol. 2017;255(7):1375\u201383.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"741_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00417-020-04931-1","volume":"259","author":"K Hirayama","year":"2021","unstructured":"Hirayama K, Yamamoto M, Kohno T, Kyo A, Theisen-Kunde D, Brinkmann R, et al. Selective retina therapy (SRT) for macular serous retinal detachment associated with Tilted disc syndrome. Graefes Arch Clin Exp Ophthalmol. 2021;259(2):387\u201393.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"741_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000520187","volume":"245","author":"SH Jeon","year":"2022","unstructured":"Jeon SH, Kim M, Lee J, Roh YJ. The effect of selective retina therapy for Bevacizumab-Resistant chronic central serous chorioretinopathy. Ophthalmologica. 2022;245(1):91\u2013100.","journal-title":"Ophthalmologica"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00741-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00741-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00741-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:24:43Z","timestamp":1763738683000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00741-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00741-x","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of Yeouido St. Mary\u2019s Hospital (number: SC25RISI0077) of the Catholic University of Korea, and the requirement for informed consent was waived due to the retrospective nature of the study. The study was conducted in accordance with the guidelines outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Young-Jung Roh is the founder and CEO of Threshold Inc., which holds a patent on fundus image\u2013based titration (Korea Patent No. 2739441). The study was conducted independently and received no financial support from Threshold Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}